Abstract
Certain clinical and experimental observations appear to indicate that dietary1–3 and/or pharmacological4,5 measures aimed at reducing metabolic risk factors of coronary heart disease (first and foremost cholesterolaemia) may alter bile composition thus favouring gallstone formation. Epidemio-logical data, too, seem to point in this direction although they are not univocal6–10.
For the composition of the Group see p. xi
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Grundy, S. M. (1975). Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia. J. Clin. Invest., 51, 273–292
Lewis, B. (1958). Effect of certain dietary oils on bile-acid secretion and serum-cholesterol. Lancet, 1, 1090–1092
Lindstedt, S., Avigan, J., Goodman, D. S., Sjovall, J. and Steinberg, D. (1965). The effect of dietary fat on the turnover of cholic acid and on the composition of the biliary bile acids in man. J. Clin. Invest., 44, 1754–1765
Pertsemlidis, D., Panveliwalla, D. and Ahrens, E. H. Jr. (1974). Effects of Clofibrate and of an estrogen-progestin combination on fasting biliary lipids and cholic acid kinetics in man. Gastroenterology, 66, 565–573
Angelin, B., Einarsson, K. and Leijd, B. (1979). Biliary lipid composition during treatment with different hypolipidaemic drugs. Eur. J. Clin. Invest., 9, 185–190
Sturdevant, R. A. L., Pearce, M. L. and Dayton, S. (1973). Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet. N. Engl. J. Med., 288, 24–27
The Coronary Drug Project Research Group (1977). Gallbladder disease as a side effect of drugs influencing lipid metabolism. N. Engl. J. Med., 296, 1185–1190
Cooper, J.,Geizerova, H. and Oliver, M.F. (1975). Clofibrate and gallstones. Lancet, 1, 1083
The Committee of Principal Investigators (1978). A co-operative trial in the primary prevention of ischaemic heart disease using Clofibrate. Br. Heart J., 40, 1069–1118
Miettinen, M., Turpeinen, O., Karvonen, M. J., Paavilainen, E. and Elosuo, R. (1976). Prevalence of cholelithiasis in men and women ingesting a serum-cholesterol-lowering diet. Ann. Clin. Res., 8, 111–116
W.H.O. European Collaborative Group (1974). An international controlled trial in the multifactorial prevention of coronary heart disease. Int. J. Epidemiol., 3, 219–224
Research Group of the Rome Project of Coronary Heart Disease Prevention (1976). The Rome Project of Coronary Heart Disease Prevention. Ann. Ist. Sup. Sanit., 12, 316–330
Mariotti, S., Verdecchia, A., Capocaccia, R., Conti, S., Farchi, G. and Menotti, A. (1977). Identificazione di soggetti ad alto rischio nel Progetto Romano di Prevenzione della Cardiopatia Coronarica. G. Ital. Cardiol., 7, 141–146
Gruppo di Ricerca del Progetto Romano di Prevenzione della Cardiopatia Coronarica (1982). Il Progetto Romano di Prevenzione della Cardiopatia Coronarica. Risultati finali. G. Ital. Cardiol., 12, 541–554.
Author information
Consortia
Editor information
Rights and permissions
Copyright information
© 1984 MTP Press Limited
About this chapter
Cite this chapter
Urbinati, G.C., the GREPCO Group. (1984). Prevention of coronary heart disease and risk of cholelithiasis. In: Capocaccia, L., Ricci, G., Angelico, F., Angelico, M., Attili, A.F. (eds) Epidemiology and Prevention of Gallstone Disease. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-5606-3_25
Download citation
DOI: https://doi.org/10.1007/978-94-009-5606-3_25
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8972-2
Online ISBN: 978-94-009-5606-3
eBook Packages: Springer Book Archive